
|Videos|November 16, 2020
Data from the PACIFIC Trial in Stage 3 Non-Small Cell Lung Cancer
Author(s)Targeted Oncology
Dr David Spigel provides information on the PACIFIC trial, including the 4-year update.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
Illuminating the Sequence of Third-Line Therapies in Metastatic CRC
5






































